DDC and Parkinson disease: Due to its key role in dopamine synthesis, AADC gene therapy has been investigated in primate models of PD, targeting striatal cells (aiming to replenish dopamine in a depleted system from SNc degeneration), with concomitant administration of lower doses of L-dopa [37].